TRANSCLERAL CYCLOPHOTOCOAGULATION

Mualliflar

  • Ulug’bek Hoshimov Ophthalmologist, laser-microsurgeon at the Bukhara branch of the scientific and practical Medical Center of specialized eye microsurgery of the Republic Uzbekistan. Muallif

;

Glaucoma, microimpulse transcleral cyclophotocoagulation, literature review, safety, efficacy.

Abstrak

Cyclophotocoagulation is a unique method of treating complex eye diseases. The method is prescribed in the case of a blind eye, with constant pain syndrome and in the final terminal stage of glaucoma. The unpredictability of the hypotensive effect and a number of serious complications during continuous wave cyclophotocoagulation (CFC) limit the use of this operation in the treatment of glaucoma, which led to the development of a new approach known as microimpulse transcleral CFC (mCFC).

Iqtiboslar

Egorov E.A., ed. The National Guide to Glaucoma. 3rd ed. Moscow: GEOTAR-Media; 2013:

Quigley H.A., Broman A.T. The number of people with glaucoma worldwide in 2010 and 2020. Br. J. Ophthalmol. 2006;

Nesterov A.P., Egorov E.A., Egorov A.E., Katz D.V. The effect of transcleral laser cyclocoagulation on intraocular pressure and visual functions in patients with open-angle advanced glaucoma. Bulletin of Ophthalmology. 2001

Petersen–Jones S., Crispin S. BSAVA Manual of Small Animal Ophthalmology. 2002.

Nashr qilingan

2024-08-31

Iqtibos keltirish tartibi

TRANSCLERAL CYCLOPHOTOCOAGULATION. (2024). Yevroosiyo Tibbiyot Va Tabiiy Fanlar Jurnali, 4(8), 44-47. https://in-academy.uz/index.php/EJMNS/article/view/10694